Cleared Traditional

K191114 - Ellipsys Vascular Access System (Ellipsys System), Power Controller, Ellipsys Vascular Access System (Ellipsys System), Catheter, Ellipsys Vascular Access System (Ellipsys System), Needle (FDA 510(k) Clearance)

Aug 2019
Decision
105d
Days
Class 2
Risk

K191114 is an FDA 510(k) clearance for the Ellipsys Vascular Access System (Ellipsys System), Power Controller, Ellipsys Vascular Access System (Ellipsys System), Catheter, Ellipsys Vascular Access System (Ellipsys System), Needle. This device is classified as a Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access (Class II - Special Controls, product code PQK).

Submitted by Avenu Medical (San Juan Capistrano, US). The FDA issued a Cleared decision on August 9, 2019, 105 days after receiving the submission on April 26, 2019.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1252. Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access. This Device Is A Single Use Percutaneous Catheter System That Creates An Arteriovenous Fistula In The Arm Of Patients With Chronic Kidney Disease Who Need Hemodialysis..

Submission Details

510(k) Number K191114 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2019
Decision Date August 09, 2019
Days to Decision 105 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PQK - Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1252
Definition Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access. This Device Is A Single Use Percutaneous Catheter System That Creates An Arteriovenous Fistula In The Arm Of Patients With Chronic Kidney Disease Who Need Hemodialysis.